Press Releases
Abbott’s Absorb™, the First Fully Dissolving Heart Stent, Earns Positive Review by FDA Advisory Committee
Abbott announced that an independent panel of experts convened by the U.S. Food and Drug Administration (FDA) voted 9 to 0, with one abstention,...
News
Lundbeck starts clinical phase III program with Lu AF35700
H. Lundbeck A/S announced that the investigational compound Lu AF35700, a novel antipsychotic, is entering clinical phase III program. Lundbeck is...
Press Releases
OncoQR ML GmbH and TYG Oncology, Ltd Expand their Collaboration Against Cancers
TYG oncology, a UK biotechnology company specializing in hormone neutralization therapy for gastrointestinal cancers, and OncoQR ML GmbH, an Austrian biotechnology company specializing in...
Press Releases
The Health Industry Summit stirs investor frenzy over China’s healthcare sector with double-digit growth
In the summer of 2015, an event drew record-breaking single-day crowds of over 170,000 professionals to Shanghai solely for the healthcare sector. It was...
Research Insight
Studies Show Ixekizumab Improved Work Productivity for Patients with Moderate-to-Severe Plaque Psoriasis
Eli Lilly and Company announced that JAMA Dermatology has published detailed results from three pivotal Phase 3 trials that evaluated the effect of ixekizumab...
Techno Trends
McKesson Launches NEW Drug Spend Intelligence Tool
McKesson announced the launch of its new Drug Spend Intelligence™ tool. Designed by hospital pharmacists, Drug Spend Intelligence is an easy-to-use online tool that...
Press Releases
Promising Excipient&Dosage Market and Rigid Social Demand for BPCs
CPhI China, hosted by UBM EMEA and China Chamber of Commerce of Medicines & Health Products Importers & Exporters and co-organized by UBM Sinoexpo,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read